½ÃÀ庸°í¼­
»óǰÄÚµå
1606830

¼¼°èÀÇ ÀüÀÚȯÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç° À¯Çü, Àü°³ ÇüÅÂ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Electronic Patient Diaries & ePRO Solutions Market by Product Type, Deployment Mode, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀüÀÚȯÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 35¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 36¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.19%·Î ¼ºÀåÇØ 2030³â¿¡´Â 57¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀüÀÚ È¯ÀÚ ÀÏÁö(ePD) ¹× ÀüÀÚ È¯ÀÚº¸°í °á°ú(ePRO) ¼Ö·ç¼ÇÀº °Ç°­ »óÅÂ¿Í Ä¡·á ¹ÝÀÀ¿¡ ´ëÇÑ È¯ÀÚ¿¡¼­ Á÷Á¢ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ ¼öÁýÇÏ´Â µ¥ »ç¿ëµÇ´Â µðÁöÅÐ Ç÷§ÆûÀÔ´Ï´Ù. ȯÀÚ Âü¿©, °Ç°­ °ü¸® ÇÁ·Î¼¼½ºÀÇ °£¼ÒÈ­¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÓ»ó½ÃÇè ¹× È¯ÀÚ °ü¸®¿¡¼­ ePD¿Í ePROÀÇ Çʿ伺Àº µ¥ÀÌÅÍ ½Å·Ú¼º°ú ȯÀÚ ±ÔÁ¤ Áؼö¸¦ °­È­ÇÏ°í ±ÔÁ¦ ´ç±¹¿¡ Á¦ÃâÇÏ´Â µ¥ ÇʼöÀûÀΠȯÀÚº¸°í µ¥ÀÌÅÍÀÇ Ç°ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ Àû¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ °á°ú´Â ÀÓ»ó ¿¬±¸, ¸¸¼º Áúȯ °ü¸®, ½ÃÆÇ ÈÄ Á¶»ç µî¿¡¼­ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµË´Ï´Ù. ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ºÐ»ê ÀÓ»ó½ÃÇèÀÇ Ã¤¿ë Áõ°¡, °Ç°­ °ü¸®ÀÇ ±Þ¼ÓÇÑ µðÁöÅÐ º¯Çõ, ȯÀÚ Áß½ÉÀÇ °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ ÃßÁø µîÀÌ ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ½Ã½ºÅÛ°ú ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ¾î »ç¿ëÀÚ °æÇè°ú µ¥ÀÌÅÍ ºÐ¼® È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â º¸´Ù °³ÀÎÈ­µÈ AI °­È­Çü ePRO ¼Ö·ç¼Ç °³¹ß¿¡ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á, ³ôÀº °³¹ß ºñ¿ë ¹× ´ÜÆíÀû ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©¿Í °°Àº °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¾ÈÀüÇÑ µ¥ÀÌÅÍ °ü¸® ±â¼úÀÇ Çõ½Å¿¡ ÁÖ·ÂÇÏ°í ±ÔÁ¦ ±â°ü°ú Çù·ÂÇÏ¿© Ç¥ÁØÈ­ µÈ ÁöħÀ» ¼ö¸³ÇؾßÇÕ´Ï´Ù.±â¼ú Çõ½Å¿¡ ÀûÇÕÇÑ ºÐ¾ß·Î´Â ¿¹Ãø ÅëÂû·ÂÀ» À§ÇÑ °í±Þ ºÐ¼®°ú ¸Ó½Å·¯´× ÅëÇÕ, ȯÀÚ ¾îµåÈ÷¾î·±½º¸¦ Çâ»ó½ÃŰ´Â ÀûÀÀÇü »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º, µ¥ÀÌÅÍ º¸¾ÈÀ» °­È­ÇÏ´Â ºí·ÏüÀÎ ±â¼ú µîÀÌ ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ePD ¹× ePRO ½ÃÀå¿¡´Â ±â¼úÀû Áøº¸¿Í Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ÅëÇÑ Å« ¼ºÀå ±âȸ°¡ Á¸ÀçÇÏÁö¸¸ °úÁ¦¸¦ ±Øº¹Çϱâ À§Çؼ­´Â Çõ½Å°ú ÄÄÇöóÀ̾𽺠Áؼö¸¦ À§ÇØÀÇ Çù·ÂÀûÀÎ ³ë·ÂÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 35¾ï ´Þ·¯
ÃßÁ¤³â(2024) 36¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 57¾ï ´Þ·¯
CAGR(%) 7.19%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀüÀÚȯÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. °áÁ¤ÀÇ Á¤±³È­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¦¾à ºÎ¹®ÀÇ ¿¬±¸ °³¹ßºñ Áõ°¡
    • ÀǾàǰ °³¹ß ÇÁ·Î±×·¥ÀÇ ±ÞÁõ
    • °¢±¹¿¡¼­ÀÇ ÀÓ»ó½ÃÇèÀÇ ¼¼°èÈ­
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç°ú °ü·ÃµÈ µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • °í±Þ ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç °³¹ß
    • ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½ºÀÇ µðÁöÅÐÈ­
  • ½ÃÀåÀÇ °úÁ¦
    • ÇÑÁ¤µÈ Áö½Ä°ú ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡ÀÇ ÀÌ¿ë °¡´É¼º

Porter's Five Force : ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ º¸°í¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹ÃøÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µË´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À§ Æ÷Áö¼Å´Ï À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕÀÇ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÀüÀÚȯÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±âÀ§ÇÑ ½Ã½ºÅÛÀ» ±¸Ãà ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ÀǾàǰ ºÐ¾ß¿¡¼­ÀÇ ¿¬±¸°³¹ßºñ Áõ°¡
      • ÀǾàǰ °³¹ß ÇÁ·Î±×·¥ÀÇ ±ÞÁõ
      • °æÁ¦¿¡¼­ÀÇ ÀÓ»ó½ÃÇèÀÇ ¼¼°èÈ­
    • ¾ïÁ¦¿äÀÎ
      • ÀüÀÚ ÀÏ±â ¹× ePRO ¼Ö·ç¼Ç°ú °ü·ÃµÈ µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£ ¿ì·Á
    • ±âȸ
      • °í±Þ ÀüÀÚ Àϱâ¿Í ePRO ¼Ö·ç¼Ç °³¹ß
      • ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½ºÀÇ µðÁöÅÐÈ­
    • °úÁ¦
      • ÇÑÁ¤µÈ Áö½Ä°ú ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡ÀÇ Á¸Àç
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀüÀÚȯÀÚ ÀÏÁö?ePRO ¼Ö·ç¼Ç ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÀÓ»ó µ¥ÀÌÅÍ °ü¸® ½Ã½ºÅÛ
  • ÀÓ»ó½ÃÇè °ü¸® ½Ã½ºÅÛ
  • ÀüÀÚ µ¥ÀÌÅÍ Ä¸Ã³
  • ·£´ýÈ­¿Í ½ÃÇè °ø±Þ °ü¸®

Á¦7Àå ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå : Àü°³ ¸ðµåº°

  • Ŭ¶ó¿ìµå ±â¹ÝÀÇ ÀüÀÚ ÀÓ»ó ¼Ö·ç¼Ç
  • ¿ÂÇÁ·¹¹Ì½º ÀüÀÚ ÀÓ»ó ¼Ö·ç¼Ç

Á¦8Àå ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • °è¾à¿¬±¸±â°ü
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀüÀÚȯÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀüÀÚ È¯ÀÚ ÀÏÁö ¹× ePRO ¼Ö·ç¼Ç ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Acquven Business Solutions Pvt. Ltd.
  • Anju Software, Inc.
  • ArisGlobal LLC
  • AssisTek
  • Castor EDC
  • Clinical Ink
  • Crucial Data Solutions, Inc.
  • Curebase Inc.
  • DATATRAK International, Inc.
  • Ennov
  • ICON PLC
  • IVR Clinical Concepts Inc.
  • Kayentis SAS
  • Medable, Inc.
  • Medidata Solutions, Inc.
  • Mednet
  • Medrio, Inc.
  • OpenClinica, LLC
  • Signant Health
  • WIRB-Copernicus Group, Inc.
JHS 24.12.16

The Electronic Patient Diaries & ePRO Solutions Market was valued at USD 3.50 billion in 2023, expected to reach USD 3.69 billion in 2024, and is projected to grow at a CAGR of 7.19%, to USD 5.70 billion by 2030.

Electronic Patient Diaries (ePDs) and electronic Patient-Reported Outcomes (ePRO) Solutions are digital platforms used for collecting real-time data directly from patients about their health conditions and treatment responses. This technology is becoming crucial in clinical trials and patient care due to the growing demand for data accuracy, patient engagement, and streamlined healthcare processes. The necessity of ePDs and ePROs arises from their application in enhancing data reliability and patient compliance, thereby improving the quality of patient-reported data critical for regulatory submissions. They are used extensively in clinical research, chronic disease management, and post-marketing surveillance. End-users include pharmaceutical companies, research organizations, and healthcare providers. Key factors driving market growth include increasing adoption of decentralized trials, rapid digital transformation in healthcare, and the ongoing push for patient-centric healthcare solutions. Opportunities lie in the development of more personalized and AI-enhanced ePRO solutions that can seamlessly integrate with existing healthcare systems, thus improving user experience and data interpretation efficiency. However, challenges such as data privacy concerns, high development costs, and fragmented regulatory frameworks can impede market growth. To overcome these limitations, companies should focus on innovation in secure data management technologies and collaborate with regulatory bodies to establish standardized guidelines. Areas ripe for innovation include the integration of advanced analytics and machine learning for predictive insights, adaptive user interfaces to improve patient adherence, and blockchain technology for enhanced data security. Understanding market trends and consumer needs is crucial for creating value-driven solutions. Overall, the ePD and ePRO market presents significant opportunities for growth through technological advancements and strategic partnerships, although navigating the challenges will require a concerted effort in innovation and compliance adherence.

KEY MARKET STATISTICS
Base Year [2023] USD 3.50 billion
Estimated Year [2024] USD 3.69 billion
Forecast Year [2030] USD 5.70 billion
CAGR (%) 7.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electronic Patient Diaries & ePRO Solutions Market

The Electronic Patient Diaries & ePRO Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing R&D expenditure in the pharmaceutical sector
    • Rapidly rising drug development programs
    • Globalization of clinical trials in economies
  • Market Restraints
    • Data security and privacy concerns associated with E-diaries and ePRO solutions
  • Market Opportunities
    • Development of advanced E-diaries and ePRO solutions
    • Digitalization of clinical trial processes
  • Market Challenges
    • Limited knowledge and availability of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Electronic Patient Diaries & ePRO Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electronic Patient Diaries & ePRO Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electronic Patient Diaries & ePRO Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electronic Patient Diaries & ePRO Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electronic Patient Diaries & ePRO Solutions Market

A detailed market share analysis in the Electronic Patient Diaries & ePRO Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electronic Patient Diaries & ePRO Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electronic Patient Diaries & ePRO Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electronic Patient Diaries & ePRO Solutions Market

A strategic analysis of the Electronic Patient Diaries & ePRO Solutions Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electronic Patient Diaries & ePRO Solutions Market, highlighting leading vendors and their innovative profiles. These include Acquven Business Solutions Pvt. Ltd., Anju Software, Inc., ArisGlobal LLC, AssisTek, Castor EDC, Clinical Ink, Crucial Data Solutions, Inc., Curebase Inc., DATATRAK International, Inc., Ennov, ICON PLC, IVR Clinical Concepts Inc., Kayentis SAS, Medable, Inc., Medidata Solutions, Inc., Mednet, Medrio, Inc., OpenClinica, LLC, Signant Health, and WIRB-Copernicus Group, Inc..

Market Segmentation & Coverage

This research report categorizes the Electronic Patient Diaries & ePRO Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Clinical Data Management Systems, Clinical Trial Management Systems, Electronic Data Capture, and Randomization & Trial Supply Management.
  • Based on Deployment Mode, market is studied across Cloud-Based E-Clinical Solutions and On-Premise E-Clinical Solutions.
  • Based on End User, market is studied across Contract Research Organizations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing R&D expenditure in the pharmaceutical sector
      • 5.1.1.2. Rapidly rising drug development programs
      • 5.1.1.3. Globalization of clinical trials in economies
    • 5.1.2. Restraints
      • 5.1.2.1. Data security and privacy concerns associated with E-diaries and ePRO solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced E-diaries and ePRO solutions
      • 5.1.3.2. Digitalization of clinical trial processes
    • 5.1.4. Challenges
      • 5.1.4.1. Limited knowledge and availability of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electronic Patient Diaries & ePRO Solutions Market, by Product Type

  • 6.1. Introduction
  • 6.2. Clinical Data Management Systems
  • 6.3. Clinical Trial Management Systems
  • 6.4. Electronic Data Capture
  • 6.5. Randomization & Trial Supply Management

7. Electronic Patient Diaries & ePRO Solutions Market, by Deployment Mode

  • 7.1. Introduction
  • 7.2. Cloud-Based E-Clinical Solutions
  • 7.3. On-Premise E-Clinical Solutions

8. Electronic Patient Diaries & ePRO Solutions Market, by End User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations
  • 8.3. Pharmaceutical & Biotechnology Companies

9. Americas Electronic Patient Diaries & ePRO Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electronic Patient Diaries & ePRO Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electronic Patient Diaries & ePRO Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acquven Business Solutions Pvt. Ltd.
  • 2. Anju Software, Inc.
  • 3. ArisGlobal LLC
  • 4. AssisTek
  • 5. Castor EDC
  • 6. Clinical Ink
  • 7. Crucial Data Solutions, Inc.
  • 8. Curebase Inc.
  • 9. DATATRAK International, Inc.
  • 10. Ennov
  • 11. ICON PLC
  • 12. IVR Clinical Concepts Inc.
  • 13. Kayentis SAS
  • 14. Medable, Inc.
  • 15. Medidata Solutions, Inc.
  • 16. Mednet
  • 17. Medrio, Inc.
  • 18. OpenClinica, LLC
  • 19. Signant Health
  • 20. WIRB-Copernicus Group, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦